Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128525) titled 'Development and application of an intelligent diagnosis and treatment system for hearing and speech disability' on July 22.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Shanghai Sixth People's Hospital
Condition:
Patients with severe to profound sensorineural hearing loss
Intervention:
Control group:Routine rehabilitation training
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-22
Target Sample Size: Control group:150;Experimental groups:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...